Minapharm Pharmaceuticals (MIPH) trades on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector. Last updated 28 Oct 2026, 10:30 (Cairo time).
What is Minapharm Pharmaceuticals’s share price today? MIPH last traded at EGP 763 (+0.66% on the day), for a market value of EGP 8.40 billion and a dividend yield of 0.33%. Its 52-week range is EGP 302.22 to 1,000.
Price change from EGX closing prices, adjusted for recorded splits and bonus issues; cash dividends are not included. A period that spans an unexplained price jump is not shown. Past performance does not indicate future results.
Minapharm Pharmaceuticals engages in the manufacture and marketing of pharmaceutical products. It offers products that specialize in gastroenterology, ophthalmology, dermatology, cardiology, biogenetics and orthopedics. The company was founded by Saad El Bardissi in 1958 and is headquartered in Cairo, Egypt.
Data as of 28 Oct 2026, 10:30 (Cairo time). EGX market data; financial statements from company disclosures. Prices are delayed 15 minutes during EGX trading hours (Sun–Thu).